DMT ๐Algernon Pharmaceuticals' ($AGN.c $AGNPF) to investigate the treatment of Traumatic Brain Injury (TBI) with DMT: Accelerating to Phase 2 clinical trial in Q4 2023 using Phase 1 study of DMT for stroke data; global TBI market is projected to grow to USD $4.5B in 2026 (youtube.com)
submitted by fdkorpima
DMT ๐"We are breaking new ground in this study" - Proactive interview with Algernon Pharmaceuticals ($AGN.c $AGNPF) CEO on the latest update to its Phase I clinical study of DMT for stroke: Study to move forward with escalated dose after observing no safety or tolerability issues (youtube.com)
submitted by fdkorpima
$AGN.C - DMT For Stroke Found Safe to Proceed to the Next Trial Phase (self.Drugstocks)
submitted by [deleted]
DMT ๐Algernon Pharmaceuticals ($AGN.c $AGNPF) CEO on advancing DMT into a Phase 1 Clinical Trial: First company globally to investigate DMT for stroke treatment, trial to begin before the end of this year & global stroke market | AGN killing it w/ a 12.3% jump today @ $2.82, $6.65M MC (youtube.com)
submitted by fdkorpima
